Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR3824 (henagliflozin) in healthy subjects
NCT02356224Phase 1Completed
- Sponsor
- Hengrui
- Start
- Jun 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of henagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Hengrui. Started Jun 2013; status: completed.
02
Drugs
henagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02356224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02356224.